Francesca M. Conway

Dovehouse Street
London, ENG SW36LY, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

COPD Biologics: Right Patient, Right Pathway, Right Time.

COPD Biologics: Right Patient, Right Pathway, Right Time.

Journal: Pulmonary therapy

Published: May 01, 2026

The relationship between plasma favipiravir concentrations and clinical outcomes in COVID-19.

The relationship between plasma favipiravir concentrations and clinical outcomes in COVID-19.

Journal: ERJ open research

Published: November 14, 2025

Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).

Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).

Journal: American journal of respiratory and critical care medicine

Published: September 08, 2025

Development and evaluation of an international teleproctoring program for bronchoscopic procedures.

Development and evaluation of an international teleproctoring program for bronchoscopic procedures.

Journal: iScience

Published: May 09, 2024

Singing for lung health in COPD: a multicentre randomised controlled trial of online delivery.

Singing for lung health in COPD: a multicentre randomised controlled trial of online delivery.

Journal: BMJ open respiratory research

Published: February 08, 2024

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.

Journal: The Lancet. Respiratory medicine

Published: June 09, 2022

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection.

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection.

Journal: American journal of respiratory and critical care medicine

Published: May 13, 2022

Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2.

Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2.

Journal: Respiration; international review of thoracic diseases

Published: May 12, 2022

COVID-19, Acute Myocardial Injury, and Infarction.

COVID-19, Acute Myocardial Injury, and Infarction.

Journal: Cardiac electrophysiology clinics

Published: February 28, 2022

Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the UK POETIC survey.

Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the UK POETIC survey.

Journal: The European respiratory journal

Published: September 19, 2021

Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD.

Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD.

Journal: Respiratory medicine

Published: August 10, 2021

Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema.

Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema.

Journal: Respiration; international review of thoracic diseases

Published: January 13, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026